Disgraced US biotech entrepreneur, convicted of defrauding investors of hundreds of millions of dollars, will serve time at minimum-security federal facility

Disgraced tech CEO gets 135 months for lying to investors about startup's capacity to revolutionize blood testing, raising over $1 billion though its technology didn't work

Both sides agree to request that US court postpones hearing, due to ongoing fraud trial of biotech firm's COO Balwani

Trial exposed hi-tech hustle culture that enabled company to raise hundreds of millions from investors for a disease-spotting product that didn't work